BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 26671595)

  • 1. t(15;21) translocations leading to the concurrent downregulation of RUNX1 and its transcription factor partner genes SIN3A and TCF12 in myeloid disorders.
    L'Abbate A; Tolomeo D; De Astis F; Lonoce A; Lo Cunsolo C; Mühlematter D; Schoumans J; Vandenberghe P; Van Hoof A; Palumbo O; Carella M; Mazza T; Storlazzi CT
    Mol Cancer; 2015 Dec; 14():211. PubMed ID: 26671595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of a potential "hotspot" DNA region in the RUNX1 gene targeted by mitoxantrone in therapy-related acute myeloid leukemia with t(16;21) translocation.
    Ottone T; Hasan SK; Montefusco E; Curzi P; Mays AN; Chessa L; Ferrari A; Conte E; Noguera NI; Lavorgna S; Ammatuna E; Divona M; Bovetti K; Amadori S; Grimwade D; Lo-Coco F
    Genes Chromosomes Cancer; 2009 Mar; 48(3):213-21. PubMed ID: 19023877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcriptome sequencing reveals CHD1 as a novel fusion partner of RUNX1 in acute myeloid leukemia with t(5;21)(q21;q22).
    Yao H; Pan J; Wu C; Shen H; Xie J; Wang Q; Wen L; Wang Q; Ma L; Wu L; Ping N; Zhao Y; Sun A; Chen S
    Mol Cancer; 2015 Apr; 14():81. PubMed ID: 25879624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of novel Runx1 (AML1) translocation partner genes SH3D19, YTHDf2, and ZNF687 in acute myeloid leukemia.
    Nguyen TT; Ma LN; Slovak ML; Bangs CD; Cherry AM; Arber DA
    Genes Chromosomes Cancer; 2006 Oct; 45(10):918-32. PubMed ID: 16858696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RUNX1-MTG16 fusion gene in acute myeloblastic leukemia with t(16;21)(q24;q22): case report and review of the literature.
    De Braekeleer E; Douet-Guilbert N; Le Bris MJ; Morel F; Férec C; De Braekeleer M
    Cancer Genet Cytogenet; 2008 Aug; 185(1):47-50. PubMed ID: 18656694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A distinct epigenetic signature at targets of a leukemia protein.
    Rossetti S; Hoogeveen AT; Liang P; Stanciu C; van der Spek P; Sacchi N
    BMC Genomics; 2007 Feb; 8():38. PubMed ID: 17266773
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two novel translocations disrupt the RUNX1 gene in acute myeloid leukemia.
    Dai H; Xue Y; Pan J; Wu Y; Wang Y; Shen J; Zhang J
    Cancer Genet Cytogenet; 2007 Sep; 177(2):120-4. PubMed ID: 17854666
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RUNX1 translocations in malignant hemopathies.
    De Braekeleer E; Férec C; De Braekeleer M
    Anticancer Res; 2009 Apr; 29(4):1031-7. PubMed ID: 19414342
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CLCA2, a novel RUNX1 partner gene in a therapy-related leukemia with t(1;21)(p22;q22).
    Giguère A; Hébert J
    Cancer Genet Cytogenet; 2010 Oct; 202(2):94-100. PubMed ID: 20875871
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RUNX1 translocations and fusion genes in malignant hemopathies.
    De Braekeleer E; Douet-Guilbert N; Morel F; Le Bris MJ; Férec C; De Braekeleer M
    Future Oncol; 2011 Jan; 7(1):77-91. PubMed ID: 21174539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Repression of vascular endothelial growth factor expression by the runt-related transcription factor 1 in acute myeloid leukemia.
    Ter Elst A; Ma B; Scherpen FJ; de Jonge HJ; Douwes J; Wierenga AT; Schuringa JJ; Kamps WA; de Bont ES
    Cancer Res; 2011 Apr; 71(7):2761-71. PubMed ID: 21447743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute promyelocytic leukemia relapsing as secondary acute myelogenous leukemia with translocation t(3;21)(q26;q22) and RUNX1-MDS1-EVI1 fusion transcript.
    Park TS; Choi JR; Yoon SH; Song J; Kim J; Kim SJ; Kwon O; Min YH
    Cancer Genet Cytogenet; 2008 Dec; 187(2):61-73. PubMed ID: 19027486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LPXN, a member of the paxillin superfamily, is fused to RUNX1 in an acute myeloid leukemia patient with a t(11;21)(q12;q22) translocation.
    Dai HP; Xue YQ; Zhou JW; Li AP; Wu YF; Pan JL; Wang Y; Zhang J
    Genes Chromosomes Cancer; 2009 Dec; 48(12):1027-36. PubMed ID: 19760607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of truncated RUNX1 and RUNX1-PRDM16 fusion transcripts in a case of t(1;21)(p36;q22)-positive therapy-related AML.
    Stevens-Kroef MJ; Schoenmakers EF; van Kraaij M; Huys E; Vermeulen S; van der Reijden B; van Kessel AG
    Leukemia; 2006 Jun; 20(6):1187-9. PubMed ID: 16598304
    [No Abstract]   [Full Text] [Related]  

  • 15. The role of topoisomerase II beta on breakage and proximity of RUNX1 to partner alleles RUNX1T1 and EVI1.
    Smith KA; Cowell IG; Zhang Y; Sondka Z; Austin CA
    Genes Chromosomes Cancer; 2014 Feb; 53(2):117-28. PubMed ID: 24327541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular characterisation of a recurrent, semi-cryptic RUNX1 translocation t(7;21) in myelodysplastic syndrome and acute myeloid leukaemia.
    Foster N; Paulsson K; Sales M; Cunningham J; Groves M; O'Connor N; Begum S; Stubbs T; McMullan DJ; Griffiths M; Pratt N; Tauro S
    Br J Haematol; 2010 Mar; 148(6):938-43. PubMed ID: 20064152
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel RUNX1-PRDM16 fusion transcripts in a patient with acute myeloid leukemia showing t(1;21)(p36;q22).
    Sakai I; Tamura T; Narumi H; Uchida N; Yakushijin Y; Hato T; Fujita S; Yasukawa M
    Genes Chromosomes Cancer; 2005 Nov; 44(3):265-70. PubMed ID: 16015645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Minimal residual disease monitoring in t(8;21) acute myeloid leukemia based on RUNX1-RUNX1T1 fusion quantification on genomic DNA.
    Duployez N; Nibourel O; Marceau-Renaut A; Willekens C; Helevaut N; Caillault A; Villenet C; Celli-Lebras K; Boissel N; Jourdan E; Dombret H; Figeac M; Preudhomme C; Renneville A
    Am J Hematol; 2014 Jun; 89(6):610-5. PubMed ID: 24616160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. t(3;21)(q26;q22) in myeloid leukemia: an aggressive syndrome of blast transformation associated with hydroxyurea or antimetabolite therapy.
    Yin CC; Cortes J; Barkoh B; Hayes K; Kantarjian H; Jones D
    Cancer; 2006 Apr; 106(8):1730-8. PubMed ID: 16532439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Double Negative Loop Comprising ETV6/RUNX1 and MIR181A1 Contributes to Differentiation Block in t(12;21)-Positive Acute Lymphoblastic Leukemia.
    Yang YL; Yen CT; Pai CH; Chen HY; Yu SL; Lin CY; Hu CY; Jou ST; Lin DT; Lin SR; Lin SW
    PLoS One; 2015; 10(11):e0142863. PubMed ID: 26580398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.